SMS Pharmaceuticals Share Price

SMS Pharma.

CMP as on 24-May-22 9:27

₹ 85.60
0.15 0.18%

Open

₹ 86.00

Turnover (lac)

₹ 1

Prev. Close

₹ 85.45

Day's Vol (shares)

₹ 673

Day's Range (₹)

₹ 85.50
₹ 86.20

CMP as on24-May-22 9:25

₹ 85.55
-0.95 -1.1%

Open

₹ 85.90

Turnover (lac)

₹ 7

Prev. Close

₹ 86.50

Day's Vol (shares)

₹ 195

Day's Range

₹ 85.55
₹ 85.90

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Feb-2022 - -
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 inter alia to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and Sec. 173 of the Companies Act 2013 that a meeting of the Board of Directors of the Company will be held on the Wednesday 9th day of February 2022 at the Registered Office of the Company inter alia for the following items: To consider and approve the Un-audited Standalone and Consolidated Financial results of the Company for the Quarter and nine months ended as on 31st December 2021. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 11th February 2022 in view of the above mentioned Board Meeting. With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following: 1. The Standalone and Consolidated Un-audited Financial Results for the third Quarter and Nine months ended 31st December, 2021 along with the Limited Review Report. (As per BSE Announcement Dated on 09/02/2022)
Board Meeting - 08-Nov-2021 - -
Quarterly Results With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following: 1. The Standalone and Consolidated Un-audited Financial Results for the Quarter and half year ended 30th September, 2021 along with the Limited Review Report. 2. Approved the resignation of Mr. V S Venkatish, Company Secretary and Compliance Officer, and he will be relieved on or before 31st January, 2022. (As per BSE Announcement Dated on 12/11/2021)
Board Meeting - 31-Jul-2021 - -
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2021 ,inter alia, to consider and approve 1. To consider and approve the Un-audited Financial results of the Company for the First Quarter ended on 30th June, 2021. 2. To consider the board report for the financial year 2020-21 3. To fix the date of Annual General Meeting for the financial year 2020-21 4. To consider the request received for reclassification of shareholding from Promoter Category to Public Category pursuant to Regulation 31(A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following: 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report 2. Reclassification of promoter group shareholding from promoter category to public category. 3. Directors Report by the Board for the FY 2020-21 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 5. Dividend Distribution Policy With reference to our earlier communication dated 31st July, 2021 we would like to inform you that the Board of Directors at its meeting held today have approved for reclassification of the following shareholders from Promoter to Public Category: (As Per BSE Announcement Dated on 07.08.2021) Further to our intimation dated 7th August, 2021, please find the enclosed herewith copies of the newspaper advertisements published on 8th August, 2021, regarding financial results for the first ended as on 30th June, 2021. Please that this information is published within 48 hours of closure of the Board Meeting as specified in Regulation 47(3) of SEBI (Listing obligations & Disclosure Requirements) regulations, 2015. (As Per BSE Announcement Dated 09.08.2021)
Board Meeting - 21-May-2021 - -
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2021 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Friday 28th day of May, 2021, at the Registered Office of the Company, inter alia, for the following items: 1. To consider and approve the Audited Standalone and consolidated Quarterly results for the fourth Quarter ended on 31st March, 2021. 2. To consider and approve Standalone and Consolidated Annual Audited Financial Statements for the financial year ended on 31st March, 2021. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 30th May, 2021 in view of the above mentioned Board Meeting. In-furtherance to our Board meeting intimation dated 21st May, 2021 and pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that in the Board Meeting scheduled to be held on Friday, 28th May, 2021, Board shall also consider declaration of dividend for the financial year 2020-21, along with other agenda(s). (As per BSE Announcement Dated on 26/05/2021) SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2021, inter alia, has considered and approved the following: - Declaration of Dividend for the year 2020-21 @ Re. 0.30/- (30%) per equity share of Re. 1/- each. Outcome of Board meeting held on 28th May, 2021. (As Per BSE Announcement Dated on 5/28/2021 5:32:45 PM)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity